Tredje AP-fonden’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,996	Closed	-$601K	–	387
2025 Q1	$601K	Hold	3,996	–	–	0.01%	409
2024 Q4	$738K	Sell	3,996 -3,996	-50%	-$770K	0.01%	441
2024 Q3	$1.57M	Hold	7,992	–	–	0.01%	406
2024 Q2	$1.65M	Sell	7,992 -126	-2%	-$28.6K	0.02%	384
2024 Q1	$2.2M	Hold	8,118	–	–	0.02%	344
2023 Q4	$1.92M	Sell	8,118 -330	-4%	-$64.9K	0.02%	389
2023 Q3	$1.66M	Sell	8,448 -790	-9%	-$162K	0.02%	407
2023 Q2	$1.94M	Sell	9,238 -1,550	-14%	-$308K	0.03%	388
2023 Q1	$2.18M	Buy	10,788 +505	+5%	+$114K	0.03%	374
2022 Q4	$2.24M	Sell	10,283 -3,468	-25%	-$757K	0.04%	350
2022 Q3	$2.71M	Buy	13,751 +10,371	+307%	+$2.24M	0.06%	261
2022 Q2	$723K	Hold	3,380	–	–	0.02%	310
2022 Q1	$960K	Hold	3,380	–	–	0.02%	318
2021 Q4	$1.27M	Buy	+3,380	New	+$1.31M	0.02%	316